Published in Biophys J on September 01, 1986
Dynamic fluorescence anisotropy imaging microscopy in the frequency domain (rFLIM). Biophys J (2002) 1.34
Biophysics of magnetic orientation: strengthening the interface between theory and experimental design. J R Soc Interface (2010) 1.32
Fretting about FRET: correlation between kappa and R. Biophys J (2007) 1.23
Recent advances in macromolecular hydrodynamic modeling. Methods (2010) 1.03
Stereo-selectivity of human serum albumin to enantiomeric and isoelectronic pollutants dissected by spectroscopy, calorimetry and bioinformatics. PLoS One (2011) 0.93
Using molecular dynamics and quantum mechanics calculations to model fluorescence observables. J Phys Chem A (2011) 0.87
Carbene footprinting accurately maps binding sites in protein-ligand and protein-protein interactions. Nat Commun (2016) 0.79
Energy transfer as a probe of protein dynamics in the proteins transferrin and calmodulin. Biophys J (1988) 0.75
Temperature-dependent X-ray diffraction as a probe of protein structural dynamics. Nature (1979) 9.27
A theory of fluorescence polarization decay in membranes. Biophys J (1977) 5.04
The internal dynamics of globular proteins. CRC Crit Rev Biochem (1981) 4.59
Dynamics of fluorescence polarization in macromolecules. Proc Natl Acad Sci U S A (1972) 3.79
Crystallographic studies of the dynamic properties of lysozyme. Nature (1979) 3.30
Subnanosecond motions of tryptophan residues in proteins. Proc Natl Acad Sci U S A (1979) 3.06
Motions in proteins. Adv Protein Chem (1979) 2.48
Molecular dynamics of an alpha-helical polypeptide: Temperature dependence and deviation from harmonic behavior. Proc Natl Acad Sci U S A (1982) 1.89
Enzyme dynamics: the statistical physics approach. Annu Rev Biophys Bioeng (1979) 1.79
Dynamic structure of biological membranes as probed by 1,6-diphenyl-1,3,5-hexatriene: a nanosecond fluorescence depolarization study. Biochemistry (1981) 1.56
Analysis of time-resolved fluorescence anisotropy decays. Biophys J (1984) 1.49
Dynamics of enzymatic reactions. Proc Natl Acad Sci U S A (1984) 1.39
Proton magnetic resonance studies of the tyrosine residues of hen lysozyme-assignment and detection of conformational mobility. Proc R Soc Lond B Biol Sci (1975) 1.15
Determination of rotational correlation times of proteins in solution from carbon-13 spin-lattice relaxation measurements. Effect of magnetic field strength and anisotropic rotation. J Am Chem Soc (1976) 1.12
Studies on the enzymic activity of lysozyme, 3. The binding of saccharides. Proc Natl Acad Sci U S A (1967) 1.11
Modelling the unusual temperature dependence of atomic displacements in proteins by local nonharmonic potentials. Proc Natl Acad Sci U S A (1981) 1.02
Photodynamic inactivation of lysozyme by eosin. Photochem Photobiol (1973) 0.96
Internal dynamics and overall motion of lysozyme studied by fluorescence depolarization of the eosin lysozyme complex. J Biomol Struct Dyn (1983) 0.93
Nuclear magnetic resonance studies of amino acids and proteins. Rotational correlation times of proteins by deuterium nuclear magnetic resonance spectroscopy. Biochemistry (1983) 0.91
Energy states of proteins, enzymes and membranes. Proc R Soc Lond B Biol Sci (1978) 0.87
A hydrogen-exchange study of lysozyme conformation changes induced by inhibitor binding. Biochemistry (1974) 0.86
Protein mobility and self-association by deuterium nuclear magnetic resonance. Biochemistry (1979) 0.84
Secondary structure and dynamics of glucagon in solution. Biochim Biophys Acta (1982) 0.80
Dynamic proteins. Nature (1983) 0.79
Antenna size dependence of fluorescence decay in the core antenna of photosystem I: estimates of charge separation and energy transfer rates. Proc Natl Acad Sci U S A (1987) 2.40
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology (Berl) (1995) 2.07
An unusual pathway of excitation energy deactivation in carotenoids: singlet-to-triplet conversion on an ultrafast timescale in a photosynthetic antenna. Proc Natl Acad Sci U S A (2001) 1.95
Antenna structure and excitation dynamics in photosystem I. I. Studies of detergent-isolated photosystem I preparations using time-resolved fluorescence analysis. Biophys J (1988) 1.88
Simulations of the temperature dependence of energy transfer in the PSI core antenna. Biophys J (1992) 1.82
Can physician education lower the cost of prescription drugs? A prospective, controlled trial. Ann Intern Med (1991) 1.78
Energy transfer and trapping in the photosystem I core antenna. A temperature study. Biophys J (1992) 1.76
Dose-dependent effect of dietary meat on endogenous colonic N-nitrosation. Carcinogenesis (2001) 1.70
Picosecond fluorescence study of photosynthetic mutants of Chlamydomonas reinhardii: origin of the fluorescence decay kinetics of chloroplasts. Photochem Photobiol (1985) 1.61
Polar solvent dynamics and electron-transfer reactions. Science (1989) 1.60
Excitation transport and trapping on spectrally disordered lattices. Biophys J (1989) 1.57
Antenna structure and excitation dynamics in photosystem I. II. Studies with mutants of Chlamydomonas reinhardtii lacking photosystem II. Biophys J (1989) 1.56
Analysis of time-resolved fluorescence anisotropy decays. Biophys J (1984) 1.49
Mechanism of the initial charge separation in bacterial photosynthetic reaction centers. Proc Natl Acad Sci U S A (1991) 1.44
Femtosecond spontaneous-emission studies of reaction centers from photosynthetic bacteria. Proc Natl Acad Sci U S A (1992) 1.42
Tunable two-dimensional femtosecond spectroscopy. Opt Lett (2004) 1.24
Neurochemical changes following kainic acid lesions of the nucleus accumbens: implications for a GABAergic accumbal-ventral tegmental pathway. Life Sci (1978) 1.19
Increased dopamine-receptor sensitivity in schizophrenia. Lancet (1978) 1.15
Internal motion and electron transfer in proteins: a picosecond fluorescence study of three homologous azurins. Biochemistry (1987) 1.14
Picosecond time-resolved fluorescence of ribonuclease T1. A pH and substrate analogue binding study. Biophys J (1987) 1.13
Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat. Br J Pharmacol (1994) 1.13
Femtosecond dynamics of the forbidden carotenoid S1 state in light-harvesting complexes of purple bacteria observed after two-photon excitation. Proc Natl Acad Sci U S A (2000) 1.11
Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem (1989) 1.11
Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J (Clin Res Ed) (1981) 1.11
Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. Br J Pharmacol (2002) 1.06
Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. J Neurol Sci (1981) 1.05
Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Br J Cancer (2009) 1.05
The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience (1993) 1.04
Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs? Trends Pharmacol Sci (1995) 1.02
Photophysics of metalloazurins. Biochemistry (1990) 1.00
Inter-relationships between behavioural and neurochemical indices of supersensitivity in dopaminergic neurones [proceedings]. Br J Pharmacol (1978) 0.98
Serotonin receptor changes in dementia of the Alzheimer type. J Neurochem (1984) 0.98
The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia. Br J Pharmacol (1995) 0.98
Denervation supersensitivity in the striatonigral GABA pathway. Nature (1978) 0.94
Internal dynamics and overall motion of lysozyme studied by fluorescence depolarization of the eosin lysozyme complex. J Biomol Struct Dyn (1983) 0.93
Obesity, weight change, and risk of adenoma recurrence: a prospective trial. Endoscopy (2012) 0.93
The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole. Neuropharmacology (1992) 0.92
Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments. Adv Biochem Psychopharmacol (1983) 0.91
Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury. Mol Pharmacol (1996) 0.91
Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species. Exp Neurol (1999) 0.91
Ultrafast processes in biology. Photochem Photobiol (1984) 0.90
Dietary intake of nitrate and nitrite and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Br J Cancer (2012) 0.90
The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls. Psychopharmacology (Berl) (1978) 0.90
Meat consumption and the risk of incident distal colon and rectal adenoma. Br J Cancer (2011) 0.90
The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat. Neurodegeneration (1995) 0.90
Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol Aging (1981) 0.89
3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors. Psychopharmacology (Berl) (1981) 0.89
Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type. J Neurol Sci (1984) 0.89
Baclofen and muscimol: behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor binding. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.88
Effects of the putative antagonists phaclofen and delta-aminovaleric acid on GABAB receptor biochemistry. Br J Pharmacol (1989) 0.88
Monoamine metabolism in senile dementia of Alzheimer type. J Neurol Sci (1983) 0.88
Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors? J Clin Psychopharmacol (1982) 0.88
Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science (1983) 0.88
The fluorescence decay kinetics of in vivo chlorophyll measured using low intensity excitation. Biochim Biophys Acta (1979) 0.88
The effects of GABAB receptor agonists and antagonists on potassium-stimulated [Ca2+]i in rat brain synaptosomes. Neuropharmacology (1989) 0.87
Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial. Br J Cancer (2010) 0.87
Meat-cooking mutagens and risk of renal cell carcinoma. Br J Cancer (2011) 0.87
Fluorescence studies of rat cellular retinol binding protein II produced in Escherichia coli: an analysis of four tryptophan substitution mutants. Biochemistry (1992) 0.86
Ti:sapphire regenerative amplifier for ultrashort high-power multikilohertz pulses without an external stretcher. Opt Lett (1995) 0.86
Antiparkinson potential of delta-opioid receptor agonists. Eur J Pharmacol (2000) 0.86
Dietary intake of meat, fruits, vegetables, and selective micronutrients and risk of bladder cancer in the New England region of the United States. Br J Cancer (2012) 0.85
Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease. Neurosci Lett (1986) 0.85
The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro. Br J Pharmacol (1989) 0.85
Noradrenergic and cholinergic systems in senile dementia of Alzheimer type. Lancet (1981) 0.85
Neuropeptides in Alzheimer type dementia. J Neurol Sci (1983) 0.85
Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings. Br J Psychiatry (1979) 0.85
The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms. Br J Pharmacol (1989) 0.85
Energy transfer and trapping in photosystem I reaction centers from cyanobacteria. Proc Natl Acad Sci U S A (1995) 0.85
A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacology (1999) 0.85
Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus. Neurosci Lett (1985) 0.84
A prospective investigation of fish, meat and cooking-related carcinogens with endometrial cancer incidence. Br J Cancer (2013) 0.84
Autoradiographic distribution of dynorphin1-9 binding sites in primate brain. Neuropeptides (1986) 0.84
Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake. Neurosci Lett (1986) 0.84
Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology (1984) 0.84
The neuroprotective actions of chlormethiazole. Prog Neurobiol (1994) 0.84
An investigation of the possible interaction of clomethiazole with glutamate and ion channel sites as an explanation of its neuroprotective activity. Pharmacol Toxicol (1998) 0.83
Neurotransmitters and second messengers in aging and Alzheimer's disease. Ann N Y Acad Sci (1993) 0.83
The human neuroblastoma cell line, IMR-32 possesses a GABAA receptor lacking the benzodiazepine modulatory site. Neuropharmacology (1993) 0.83
The effect of oedema and tissue swelling on the measurement of neuroprotection; a study using chlormethiazole and permanent middle cerebral artery occlusion in rats. Neurodegeneration (1996) 0.83
Striatal dopamine receptors in Alzheimer-type dementia. Neurosci Lett (1984) 0.83
Studies on possible mechanisms of action of electroconvulsive therapy; effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters. Psychopharmacology (Berl) (1981) 0.83
Action of chlormethiazole in a model of ethanol withdrawal. Psychopharmacology (Berl) (1990) 0.83
Role of electron-transfer quenching of chlorophyll fluorescence by carotenoids in non-photochemical quenching of green plants. Biochem Soc Trans (2005) 0.82
Subclinical infections in mice resulting from the modulation of a lethal dose of Semliki Forest virus with defective interfering viruses: neurochemical abnormalities in the central nervous system. J Gen Virol (1986) 0.82
A behavioural and neurochemical study in rats of the pharmacology of loreclezole, a novel allosteric modulator of the GABAA receptor. Neuropharmacology (1996) 0.82
Identification of the GABAA receptor alpha 3 subunit in the IMR-32 neuroblastoma cell line. J Neurochem (1993) 0.82
Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington's disease and Alzheimer-type dementia. J Neurol Sci (1985) 0.82
Regional changes in [3H]D-aspartate and [3H]TCP binding sites in Alzheimer's disease brains. Brain Res (1988) 0.81
Time course of the antipsychotic effect in schizophrenia and some changes in postmortem brain and their relation to neuroleptic medication. Adv Biochem Psychopharmacol (1980) 0.81
Brain 5-HT-2 receptors and suicide. Lancet (1983) 0.81
Techniques for examining neuroprotective drugs in vivo. Int Rev Neurobiol (1997) 0.81
Postmortem neurochemical studies in depression. Ann N Y Acad Sci (1986) 0.81
Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder. J Neural Transm Suppl (1983) 0.81
Clomethiazole protects against hemineglect in a primate model of stroke. Brain Res Bull (2000) 0.80
Neurotransmitter receptors in brain in schizophrenia. Acta Psychiatr Scand Suppl (1981) 0.80
Measurements of tacrine and monoamines in brain by in vivo microdialysis argue against release of monoamines by tacrine at therapeutic doses. Br J Pharmacol (1991) 0.80
[3H] Quinuclidinyl benzylate and [3H] GABA receptor binding in rat substantia nigra after 6-hydroxy-dopamine lesions. Neurosci Lett (1980) 0.80
Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitro. Neuropharmacology (2001) 0.80